Trailing Dividend / Share
$2.47
Bristol-Myers Squibb Company Ce (CELG-RI) Dividend History
Income profile from 2020 to 2025 with payout safety and yield-on-cost trend
Dividend Yield
100.0%
Payout Ratio
71.5%
Watch
Dividend Streak
6 years
CELG-RI Dividend Income Check
Safety
71.5% payout ratio with watch safety profile.
Consistency
6 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
CELG-RI Dividend Scorecard
Yield & Income
Dividend Yield100.0%
Trailing DPS$2.47
FrequencyAnnual
Payments / 12M0
Payout Safety
Earnings Payout71.5%
Earnings SafetyWatch
FCF Payout42.4%
FCF SafetyWell Covered
Piotroski F-Score8/9
Growth
Growth Streak6 years
3Y CAGR4.6%
5Y CAGR6.5%
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield100.0%
1Y Total Return220.6%
5Y Total Return48.7%
Div Contribution (5Y)80.4%
Estimated $10K growth (return + dividends):
5Y ago$14,86710Y ago$33,61320Y ago$33,613
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
CELG-RI Income Growth Story
Dividend per share and yield on cost over time (4 years of payments)
CELG-RI Dividend Safety Story
EPS is the container — dividend is what's drawn out
Dividend Analysis
Payout Safety
Bristol-Myers Squibb Company Ce distributes 71.5% of earnings as dividends (Watch). When measured against free cash flow—a stricter test—the payout ratio stands at 42.4%, rated "Well Covered".
Piotroski F-Score: 8/9 — strong financial health.
Growth Track Record
CELG-RI has raised its dividend for 6 consecutive years, with a 3-year CAGR of 4.6% and 5-year CAGR of 6.5%.
Total Shareholder Returns
Beyond cash dividends, CELG-RI returns capital through share repurchases. The combined picture: 100.0% dividend yield, 100.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 48.7%, with dividends contributing 80.4% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $33,613 today.
CELG-RI Recent Dividend Payments
Last 4 payments · Annual
TTM Total$0.41
Avg/Payment$0.1037
Latest Change-81.0%
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| Mar 7, 2024Latest | $0.0199 | ↓ -81.0% | 36.18% | Mar 11, 2024 |
| Mar 3, 2022 | $0.1046 | ↓ -26.6% | 67.52% | Mar 7, 2022 |
| Mar 4, 2021 | $0.1425 | ↓ -3.6% | 187.46% | Mar 8, 2021 |
| Mar 18, 2020 | $0.1479 | — | 95.47% | Mar 20, 2020 |
CELG-RI Dividend vs Peers
Comparable companies in the same industry
#1 yield in peer group
Div Yield
100.0%
#1 of 8
Safety
Watch
71.5% payout
Streak
6Y
6.5% 5Y CAGR
Total Shareholder
100.0%
#1 of 8
| Company | Mkt Cap | Yield | Payout | Streak | Safety |
|---|---|---|---|---|---|
1st CELG-RIBristol-Myers Squibb… | $216M | 100.0% | 71.5% | 6 | Watch |
3rd  BMYBristol-Myers Squibb… | $114.8B | 4.4% | 71.5% | 6 | Watch |
 MRKMerck & Co., Inc. | $277.3B | 2.9% | 44.8% | 14 | Sustainable |
2nd  PFEPfizer Inc. | $150.6B | 6.5% | 1.3% | 15 | Sustainable |
 AZNAstraZeneca PLC | $283.0B | 1.8% | 49.6% | 4 | Sustainable |
 LLYEli Lilly and Compan… | $921.2B | 0.6% | 26.1% | 11 | Sustainable |
 ABBVAbbVie Inc. | $358.4B | 3.2% | 2.8% | 13 | Sustainable |
 GILDGilead Sciences, Inc… | $166.4B | 2.4% | 47.0% | 11 | Sustainable |
CELG-RI Annual Dividend History (1989–2025)
37 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | -100.0% | 0 | $3.46 | — | — | — |
| 2024 | $0.02 | — | 1 | $-4.41 | — | — | 12.8% |
| 2023 | $0.00 | -100.0% | 0 | $3.86 | — | — | — |
| 2022 | $0.10 | -26.6% | 1 | $2.95 | 3.5% | 28.21x | 67.5% |
| 2021 | $0.14 | -3.6% | 1 | $3.12 | 4.6% | 21.89x | 92.0% |
| 2020 | $0.15 | — | 1 | $-3.98 | — | — | 95.5% |
| 2019 | $0.00 | — | 0 | $2.01 | — | — | — |
| 2018 | $0.00 | — | 0 | $3.03 | — | — | — |
| 2017 | $0.00 | — | 0 | $0.61 | — | — | — |
| 2016 | $0.00 | — | 0 | $2.65 | — | — | — |
See CELG-RI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELG-RI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CELG-RI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCELG-RI — Frequently Asked Questions
Quick answers to the most common questions about buying CELG-RI stock.
How much dividend does CELG-RI pay per share?
Bristol-Myers Squibb Company Ce (CELG-RI) pays a trailing 12-month dividend of $2.47 per share, with a current dividend yield of +100.0%. Payments are made Annual.
When is CELG-RI's next ex-dividend date?
CELG-RI's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. CELG-RI typically pays dividends Annual.
Is CELG-RI's dividend safe?
CELG-RI's dividend safety is rated "Watch" based on an earnings payout ratio of +71.5% and FCF payout ratio of +42.4%. The 6-year growth streak provides moderate confidence.
Is CELG-RI a Dividend Payer?
Yes, Bristol-Myers Squibb Company Ce is classified as a Dividend Payer with 6 consecutive years of dividend increases. The 5-year dividend CAGR is +6.5%, demonstrating above-inflation dividend growth.
How often does CELG-RI pay dividends?
Bristol-Myers Squibb Company Ce pays dividends Annual. The trailing 12-month total is $2.47 per share. Dividend data on this page covers 5+ years from 2020 to 2025.
How much would $10,000 invested in CELG-RI grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in CELG-RI five years ago would be worth approximately $14,867 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is CELG-RI's yield on cost for long-term holders?
CELG-RI's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +100.0% market yield, thanks to consistent dividend growth.